Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
08/12/2009 | EP2086995A1 Hepatitis c virus inhibitors |
08/12/2009 | EP2086994A2 Inhibitors of hepatitis c virus |
08/12/2009 | EP2086990A2 Novel nucleotide analogues as percursor molecules for antivirals |
08/12/2009 | EP2086980A1 Macrocyclic peptides as hepatitis c virus inhibitors |
08/12/2009 | EP2086968A1 5-hydroxymethyl-oxazolidin-2-one derivatives |
08/12/2009 | EP2086963A2 Hepatitis c virus inhibitors |
08/12/2009 | EP2086962A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor |
08/12/2009 | EP2086943A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
08/12/2009 | EP2086941A1 Antibacterial quinoline derivatives |
08/12/2009 | EP2086940A1 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
08/12/2009 | EP2086589A2 Ultrasound microbubble mediated genes delivery system |
08/12/2009 | EP2086582A1 Vaccine comprising an oil in water emulsion adjuvant |
08/12/2009 | EP2086570A1 Use of beta-lactamase |
08/12/2009 | EP2086546A2 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties |
08/12/2009 | EP2086529A2 Antimicrobial compositions and related applications |
08/12/2009 | EP2086316A2 Subunguicide, and method for treating onychomycosis |
08/12/2009 | EP1850827A4 Composition for treating and preventing periodontal disease and method of use |
08/12/2009 | EP1635854A4 Treatment or prevention of respiratory viral infections with alpha thymosin peptides |
08/12/2009 | EP1587520B1 Bacteriophage for the treatment of bacterial biofilms |
08/12/2009 | EP1567150B1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
08/12/2009 | EP1509529B1 Esters in position 20 of camptothecins |
08/12/2009 | EP1463735B1 Imidazo¬2,1-b -1,3,4-thiadiazole sulfonamides |
08/12/2009 | EP1429771B1 Bicyclic compounds as inhibitors of chemokine binding to us28 |
08/12/2009 | EP1424895B1 Method for expression of small antiviral rna molecules within a cell |
08/12/2009 | EP1409645B1 Probiotic lactobacillus salivarius strains |
08/12/2009 | EP1379257B1 Prodrugs of anticancer agents employing substituted aromatic acids |
08/12/2009 | EP1290227B1 Compositions, kits, and methods for identification and modulation of type i diabetes |
08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
08/12/2009 | EP1123711B9 Attenuated toxins as adjuvants |
08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
08/12/2009 | EP0771322B9 Abundant extracellular products and methods for their production and use |
08/12/2009 | CN101506239A Antihuman alpha9 integrin antibody and use of the same |
08/12/2009 | CN101506171A Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
08/12/2009 | CN101506170A 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as HIV integrase inhibitor |
08/12/2009 | CN101506061A Active food pathogen inhibitor packaging |
08/12/2009 | CN101505797A Pharmaceutical compositions for the treatment of fungal infections |
08/12/2009 | CN101505767A Agent for preventing infection |
08/12/2009 | CN101505740A Improved method of treatment of bacterial infections |
08/12/2009 | CN101503725A Technique for improving purity of diphtheria toxoid |
08/12/2009 | CN101503702A Mycobacteria differential expression system, and preparation and uses thereof |
08/12/2009 | CN101503694A Rearranged bacterial virus bacteriolysis gene, perforating vector thereof and use in vaccine preparation |
08/12/2009 | CN101503686A DNA sequence for reinforcing bacterial virus bacteriolysis gene perforating efficiency and use thereof |
08/12/2009 | CN101503475A Fusion protein of anthrax lethal factor domain (LFn) and anthrax edema factor domain (EFn) and use thereof |
08/12/2009 | CN101503472A Human source neutralizing antibody specific against botulinum neurotoxin type A and use thereof |
08/12/2009 | CN101503462A Method for removing endotoxin in influenza virus stock solution |
08/12/2009 | CN101503459A Bloody noun antibacterial peptide temporin-Lb, genes thereof and use in pharmacy |
08/12/2009 | CN101503457A Column chromatography PEG and interferon analogue protein N-terminal site-directed coupling method and product thereof |
08/12/2009 | CN101503413A Preparation of 5,6-dihydro-6-methieno [2,3-b] thiopyran-2-sulfonic acid amide-4-keto |
08/12/2009 | CN101503412A Preparation of 5,6- dihydro-4-hydroxy-(S)-6- methylthieno [2,3-b] thiopyran |
08/12/2009 | CN101503410A Method for preparing high-purity podophyllotoxin from Chinese podophyllum root |
08/12/2009 | CN101503397A Halogenated furan ketone compound, and use thereof in antiinfective drug preparation |
08/12/2009 | CN101503369A Method for preparing vanillyl acidamide compounds by interfacial reaction |
08/12/2009 | CN101503356A Novel method for preparing high-purity chlorogenic acid |
08/12/2009 | CN101502668A Polyphenol-protein complexes and method for producing the same, patch containing the polyphenol-protein complexes and method for producing the same |
08/12/2009 | CN101502657A Method for constructing phage vector vaccine fused with gp350 protein of EB virus |
08/12/2009 | CN101502653A Medicament composition for preventing or treating Streptococcus suis disease |
08/12/2009 | CN101502652A Chickenpox, herpes zoster human immunoglobulin and preparation method thereof |
08/12/2009 | CN101502651A Hydrophobia, tetanus double-titer human immunoglobulin and preparation method thereof |
08/12/2009 | CN101502650A Hepatitis B nucleic acid vaccine with optimized codon |
08/12/2009 | CN101502649A Liposome influenza vaccine |
08/12/2009 | CN101502648A 疫苗 Vaccine |
08/12/2009 | CN101502631A Synergistic medicament composition containing Aolamite and Chinese medicine extract |
08/12/2009 | CN101502628A Tibetan medicine pill for influenza as well as quality criteria and inspection method of preparation thereof |
08/12/2009 | CN101502626A Medicament for treating influenza and preparation method thereof |
08/12/2009 | CN101502594A Deodorizing antipruritic tea |
08/12/2009 | CN101502593A Compound formulation of washing lotion for treating beriberi and dermatophytosis |
08/12/2009 | CN101502589A Chinese and western medicinal composition containing bifendate for auxiliary treatment of hepatitis |
08/12/2009 | CN101502584A Chinese medicine granular formulation composing for treating piglet yellow-white dysentery and technique for preparing the same |
08/12/2009 | CN101502581A Application of dry distillation liquid from jujube core in preparing medicament for treating or preventing fungal disease |
08/12/2009 | CN101502580A External-use medicament for treating tinea manus and pedis |
08/12/2009 | CN101502575A Method for preparing dry distillation liquid from cherry core |
08/12/2009 | CN101502573A Method for preparing dry distillation liquid from loquat core |
08/12/2009 | CN101502572A Auxiliary Chinese and western medicinal composition for treating hepatitis |
08/12/2009 | CN101502564A Method for preparing dry distillation liquid of olivary nucleus |
08/12/2009 | CN101502557A Body resistance-strengthening and detoxifying powder ultramicro powder preparation for animal and preparation method |
08/12/2009 | CN101502555A Externally appiled Chinese medicine for treating herpes zoster |
08/12/2009 | CN101502551A Synergistic composition containing bifendate |
08/12/2009 | CN101502550A Filifolium sibiricum effective component extract as well as preparation method and use thereof |
08/12/2009 | CN101502538A Method for preparing ginkgo episperm dry distillation liquid |
08/12/2009 | CN101502531A 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatites virus infections |
08/12/2009 | CN101502522A Acyclovir enteric sustained-release preparation composition and method for preparing the same |
08/12/2009 | CN101502521A Acyclovir sustained-release preparation composition and method for preparing the same |
08/12/2009 | CN101502520A Acyclovir enteric-coated formulation composition and method for preparing the same |
08/12/2009 | CN101502514A Rifaximin enteric sustained-release preparation composition and method for preparing the same |
08/12/2009 | CN101502513A Rifaximin sustained-release preparation composition and method for preparing the same |
08/12/2009 | CN101502512A Amoxicillin/clavulanic acid blended stock preparation and rapid determination method for evenness |
08/12/2009 | CN101502511A Amoxicillin/clavulanate potassium tablet and preparation method thereof |
08/12/2009 | CN101502510A Medicament composition for treating colpitis symptoms and preparation method thereof |
08/12/2009 | CN101502501A Anti-infective medicament composition and application |
08/12/2009 | CN101502496A Method for preparing norfloxacin capsule |
08/12/2009 | CN101502492A Method for preparing clarithromycin granule without bitter taste |
08/12/2009 | CN101502491A Dirithromycin enteric-coated formulation |
08/12/2009 | CN101502487A Suspension composition containing doxycycline and florfenicol for injection and technique for preparing the same |
08/12/2009 | CN101502324A Kava pepper extract effervescent tablet and technique for preparing the same |
08/12/2009 | CN101502315A Method for preparing dry distillation liquid for jujube core |
08/12/2009 | CN100526463C Methods for making Apo-2 ligand using divalent metal ions |
08/12/2009 | CN100526342C Method of manufacture of polyacrolein |
08/12/2009 | CN100526331C CTL epitopes from EBV |
08/12/2009 | CN100526325C Macrocyclolactone lactone kind medicine erythromycin A derivant, synthesizing process and use thereof |
08/12/2009 | CN100526313C Imidazopyridine substituted tropane derivatives with CCR5 receptor antagonist activity for the treatment of HIV and inflammation |